ACADIAN ASSET MANAGEMENT LLC

Position in CHRS — Coherus Oncology, Inc.

CIK 916542 Boston, MA

Position in CHRS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$208,917

+$9,724 QoQ

Shares Held

149,227

+26.6% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 145 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $731,256,203 across 167 Biotechnology names. CHRS ranks #114 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$208,917	149,227	+26.6%	Shares	Defined	2026-08-13
2026-03-31	$199,193	117,866	+128.2%	Shares	Defined	2026-05-13
2025-12-31	$73,328	51,640	0.0%	Shares	Defined	2026-02-10
2025-09-30	$84,689	51,640	0.0%	Shares	Defined	2025-11-13
2025-06-30	$37,748	51,640	-73.8%	Shares	Defined	2025-08-07
2025-03-31	$158,920	196,927	+52980.1%	Shares	Defined	2025-05-21
2024-12-31	$511	371	-99.3%	Shares	Defined	2025-02-11
2024-09-30	$58,702	56,445	-90.5%	Shares	Defined	2024-11-12
2023-12-31	$1,972,132	592,232	+10253.7%	Shares	Defined	2024-02-13
2022-06-30	$41,412	5,720	-93.5%	Shares	Defined	2022-08-09
2020-06-30	$1,560,803	87,391	-55.1%	Shares	Defined	2020-08-12
2020-03-31	$3,154,092	194,457	—	Shares	Defined	2020-05-11
No filing history on record for this holder in this stock.